GlobeNewswire 2020-08-18 Lifshitz Law Firm, P.C. Announces Investigation of GCI Liberty, Inc. (NASDAQ: GLIBA), National Gener...
GlobeNewswire 2020-08-14 Lifshitz Law Firm, P.C. Announces Investigation of GCI Liberty, Inc. (NASDAQ: GLIBA), MVC Capital, I...
GlobeNewswire 2020-08-14 PFNX, OTEL, JCAP, and VAR SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigati...
GlobeNewswire 2020-08-11 PFENEX INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout
GlobeNewswire 2020-08-10 MiMedx Welcomes Robert B. Stein, M.D., Ph.D., to Head Revitalized R&D Efforts
GlobeNewswire 2020-07-20 Antares Pharma Appoints Patrick Shea Senior Vice President of Commercial
GlobeNewswire 2020-07-08 Sermonix Pharmaceuticals to Collaborate With Eli Lilly and Company in Studying Combination of Lasofo...
GlobeNewswire 2020-06-18 Sermonix to Present Poster on Lasofoxifene, CDK 4/6 Inhibitor Combination for AACR Virtual Annual Me...
GlobeNewswire 2020-06-11 The Benchmark Company Announces “Healthcare House Call” Upcoming Virtual 1x1 Investor Conference
GlobeNewswire 2020-05-28 Palvella Therapeutics Completes $45 Million Series C Financing
GlobeNewswire 2020-02-27 Verona Pharma Reports Financial Results for the Full Year Ended December 31, 2019 and Provides Corpo...
GlobeNewswire 2020-02-20 INVESTOR ALERT: BDX LGND LOPE SBT: Kirby McInerney LLP Continues Investigation of Shareholder Claims
GlobeNewswire 2020-01-21 Lemelson Capital Management Reports FYE 2019 Results for The Amvona Fund, LP
GlobeNewswire 2019-11-12 Equillium Announces Leadership Updates
GlobeNewswire 2019-10-28 Vaxart, Inc. Announces Changes to its Board of Directors
GlobeNewswire 2019-09-25 Analysis on the $5.36Bn Narcolepsy Drugs Market (2019-2026): Cataplexia Expected to Experience Rapid...
GlobeNewswire 2019-09-23 Sermonix Doses First Patient in Phase 2 Clinical Trial of Lasofoxifene for Targeted Precision Medici...
GlobeNewswire 2019-09-05 Novan and Aspire Capital Enter into a Common Stock Purchase Agreement for up to $25 Million
GlobeNewswire 2019-08-26 Adamis Pharmaceuticals Announces Appointment of New Members to Its Board of Directors
GlobeNewswire 2019-07-31 Sermonix Pharmaceuticals Closes US$26 Million Series A Financing Round Led by WILD Family Office
GlobeNewswire 2019-07-30 Exagen Inc. Expands Board of Directors with its Appointment of Chet Burrell, Tina Nova and Bruce Rob...
GlobeNewswire 2019-07-19 Outlook on the Global Narcolepsy Treatment Market to 2025 - A Surge in Stress Levels & Unhealthy Lif...
GlobeNewswire 2019-06-03 Sermonix Poster Presentation at 2019 ASCO Annual Meeting Demonstrates Promise for Lasofoxifene in Tr...
GlobeNewswire 2019-05-28 Sermonix Receives FDA Fast Track Designation for Investigational Drug Lasofoxifene
GlobeNewswire 2019-05-07 Sermonix to Present Poster on ‘Lasofoxifene as a Potential Treatment for ER+ Metastatic Breast Cance...